Press Release: "TrialReach strengthens leadership team with high profile hires from Shazam, Eli Lilly, Investec and TEDMED"
London, UK and New York, NY–Sept 10th, 2015 - Following a $13.5M fundraising round led by Smedvig Capital in February, TrialReach today announced several key appointments to drive its vision of enabling patients to connect easily with clinical trials through its unique online platform.
These hires bring a wealth of expertise from various corners of the technology and health world, as TrialReach prepares to launch a smart data driven marketplace that will revolutionize the way patients can search for treatments under development.
Keith Lovell has joined the team as Chief Financial Officer, following a nine-year stint as CFO of Shazam during which he helped grow the company from a small startup to a global brand with a valuation of $1 billion. Keith, who brings over 20 years experience of financial and commercial management in a wide range of technology businesses, will also join the TrialReach Board of Directors.
David Currie, former Head of Investment Banking and Securities at Investec, has joined as non executive Chairman of the Board of Directors. David brings more than 20 years experience in the financial sector during which time he managed more than 100 companies in public and private markets.
Jeffrey Kasher, former VP of Clinical Innovation and Implementation at Eli Lilly and Company, joins the TrialReach Advisory Board. He rounds out the Advisory Board with deep knowledge of the pharmaceutical industry to help advance the TrialReach mission of connecting patients to clinical trials.
These stellar appointments follow other key recent hires, including:
Tom Krohn, former Director of Clinical Open Innovation at Lilly, as Chief Development Officer.
Joyce Haas, formerly of WebMD and Wonga.com, as VP of Product.
Dean Sellis, former Chief Architect of the Patients2Trials platform, as VP of Engineering.
James Hayden, former SVP Partnerships of Certara, as VP of Sales.
Grace McElroy and Courtney Paige, both formerly of TEDMED, as Head of Partnerships and Head of Brand and Communications.
"I am very pleased to be adding this wealth of experience and talent to the team and proud to have been able to attract individuals of this calibre", said founder and CEO Pablo Graiver."With these new hires and appointments, TrialReach is poised to successfully implement our vision to transform clinical trials and help patients globally."
About TrialReach
TrialReach is helping patients find and take part in clinical trials, so that new drugs and life saving treatments can reach the people who need them, faster. TrialReach’s smart match technology is making all clinical trials machine readable and searchable. What this means is that for the first time, patients can search thousands of trials in seconds to find a trial for them, just by answering a few simple, health related questions. By democratizing the clinical trial matching process in this way, TrialReach is empowering patients and helping to drive medical science forward. TrialReach was launched in 2010 and is based in the U.S. and the U.K. For more information, visit trialreach.com
Media Contacts
Lisa Brockway
Director of Communications
lisa@trialreach.com
6465833789
Courtney Olean Paige
Head of Branding and Communications
courtney@trialreach.com
2038033295